Indivior PLC
LSE:INDV

Watchlist Manager
Indivior PLC Logo
Indivior PLC
LSE:INDV
Watchlist
Price: 790 GBX -0.82% Market Closed
Market Cap: 1B GBX
Have any thoughts about
Indivior PLC?
Write Note

Relative Value

The Relative Value of one INDV stock under the Base Case scenario is 2 176.93 GBX. Compared to the current market price of 790 GBX, Indivior PLC is Undervalued by 64%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

INDV Relative Value
Base Case
2 176.93 GBX
Undervaluation 64%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
96
vs Industry
65
Median 3Y
2.8
Median 5Y
2.9
Industry
2.6
Forward
0
vs History
vs Industry
1
Median 3Y
11.9
Median 5Y
9
Industry
23
Forward
0.1
vs History
vs Industry
3
Median 3Y
-5.7
Median 5Y
-5.7
Industry
17.8
vs History
vs Industry
Median 3Y
-5.8
Median 5Y
-5.8
Industry
25.4
vs History
vs Industry
0
Median 3Y
12
Median 5Y
12.7
Industry
2.2
vs History
vs Industry
Median 3Y
-43.5
Median 5Y
-78.3
Industry
2.8
Forward
-0.1
vs History
vs Industry
Median 3Y
-52.3
Median 5Y
-93.3
Industry
5.4
vs History
vs Industry
2
Median 3Y
-166.6
Median 5Y
-293.7
Industry
13.7
Forward
-0.3
vs History
vs Industry
3
Median 3Y
-182.8
Median 5Y
-326.6
Industry
17.2
Forward
-0.4
vs History
34
vs Industry
27
Median 3Y
11.4
Median 5Y
11.4
Industry
16.5
vs History
34
vs Industry
27
Median 3Y
9.9
Median 5Y
9.9
Industry
19.3
vs History
vs Industry
Median 3Y
-40.8
Median 5Y
-92.1
Industry
2

Multiples Across Competitors

INDV Competitors Multiples
Indivior PLC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
UK
Indivior PLC
LSE:INDV
1.1B GBP 1.2 -9.5 -31.1 -37
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
746.8B USD 18.3 89.2 48 53.5
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.4 27.8
US
Johnson & Johnson
NYSE:JNJ
365.6B USD 4.2 24.9 12 15.7
US
Merck & Co Inc
NYSE:MRK
249.1B USD 3.9 20.5 10.4 12.4
CH
Roche Holding AG
SIX:ROG
208.6B CHF 3.6 18.1 10.2 12.1
CH
Novartis AG
SIX:NOVN
181.4B CHF 4.2 12.6 10 14.8
UK
AstraZeneca PLC
LSE:AZN
159.6B GBP 4.1 31.4 169.3 253.8
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
UK
Indivior PLC
LSE:INDV
Average P/E: 33.1
Negative Multiple: -9.5
13 812%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
89.2
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
24.9
-22%
US
Merck & Co Inc
NYSE:MRK
20.5
7 336%
CH
Roche Holding AG
SIX:ROG
18.1
32%
CH
Novartis AG
SIX:NOVN
12.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.4
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top